πŸ‡ΊπŸ‡Έ FDA
Patent

US 8697699

Imidazopyrazine SYK inhibitors

granted A61PA61P11/00A61P11/06

Quick answer

US patent 8697699 (Imidazopyrazine SYK inhibitors) held by GILEAD CONNECTICUT, INC. expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
GILEAD CONNECTICUT, INC.
Grant date
Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P11/00, A61P11/06, A61P11/08, A61P19/02